NEO (STOCKS)
NeoGenomics, Inc.
$16.060000
-0.360000 (-2.19%)
Prev close: $16.420000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Anthony P. Zook
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,182.82M
- Employees
- 2,200
- P/E (TTM)
- -40.70
- P/B (TTM)
- 2.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $766.30M |
| Benefits Costs and Expenses | $820.84M |
| Cost Of Revenue | $429.76M |
| Costs And Expenses | $820.84M |
| Gross Profit | $336.53M |
| Operating Expenses | $404.97M |
| Research and Development | $38.17M |
| Other Operating Expenses | $366.80M |
| Operating Income/Loss | -$68.44M |
| Income/Loss From Continuing Operations After Tax | -$51.88M |
| Income/Loss From Continuing Operations Before Tax | -$54.55M |
| Income Tax Expense/Benefit | -$2.67M |
| Net Income/Loss | -$51.88M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$51.88M |
| Net Income/Loss Available To Common Stockholders, Basic | -$51.88M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 387,393,000 |
| Diluted Average Shares | 388,596,000 |
| Assets | $1.35B |
| Current Assets | $381.48M |
| Inventory | $27.14M |
| Prepaid Expenses | $23.59M |
| Other Current Assets | $330.75M |
| Noncurrent Assets | $970.77M |
| Fixed Assets | $80.94M |
| Intangible Assets | $271.26M |
| Other Non-current Assets | $618.57M |
| Liabilities | $566.51M |
| Current Liabilities | $105.88M |
| Accounts Payable | $20.95M |
| Wages | $56.27M |
| Other Current Liabilities | $28.67M |
| Noncurrent Liabilities | $460.63M |
| Equity | $785.73M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $785.73M |
| Liabilities And Equity | $1.35B |
| Net Cash Flow From Operating Activities | $22.05M |
| Net Cash Flow From Operating Activities, Continuing | $22.05M |
| Net Cash Flow From Investing Activities | -$19.90M |
| Net Cash Flow From Investing Activities, Continuing | -$19.90M |
| Net Cash Flow From Financing Activities | -$11.39M |
| Net Cash Flow From Financing Activities, Continuing | -$11.39M |
| Net Cash Flow | -$9.24M |
| Net Cash Flow, Continuing | -$9.24M |
| Comprehensive Income/Loss | -$51.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$51.90M |
| Other Comprehensive Income/Loss | -$105.81M |
| Other Comprehensive Income/Loss Attributable To Parent | -$25.00K |